No abstract available
Keywords:
MYC; diffuse large B-cell lymphoma; dose-adjusted EPOCH-R.
Publication types
-
Clinical Trial, Phase II
-
Letter
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Etoposide / therapeutic use
-
Gene Rearrangement / drug effects
-
Humans
-
Lymphoma, Large B-Cell, Diffuse / diagnosis
-
Lymphoma, Large B-Cell, Diffuse / drug therapy*
-
Lymphoma, Large B-Cell, Diffuse / genetics
-
Middle Aged
-
Prednisone / therapeutic use
-
Prospective Studies
-
Proto-Oncogene Proteins c-myc / genetics*
-
Rituximab / therapeutic use*
-
Vincristine / therapeutic use
Substances
-
Proto-Oncogene Proteins c-myc
-
Rituximab
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone